QUOTE AND NEWS
Reuters  Jul 9  Comment 
July 9 - Standard & Poor's Ratings Services said today that its ratings on Philadelphia-based eResearch Technology Inc. (ERT; rated 'B' with a positive outlook) are not affected by the company's...
Benzinga  Apr 11  Comment 
Yesterday it was reported by several research firms that eResearch Technology (NASDAQ: ERT) will soon see the last of its publicly traded days, as private equity firm, Genstar Capital, is set to acquire the cardiac safety solutions company for $8...
Benzinga  Apr 11  Comment 
Benchmark lowers its rating on eResearch Technology (NASDAQ: ERT) to Hold from Buy following a sale agreement with Genstar Capital for $8 a share. The $8 price target per share remains. Benchmark says, "We are downgrading ERT shares to Hold...
Benzinga  Apr 10  Comment 
According to a research report published earlier today, Citi has downgraded eResearch Technology (NASDAQ: ERT) from Buy to Neutral, and has removed its $6 PT. In the report, Citi commented, “eResearch Technology (ERT) announces today that it...
Reuters  Apr 10  Comment 
Investment firm Genstar Capital Llc will take specialty clinical research company eResearch Technology private for $400 million, the latest in a string of private equity deals in the...
Benzinga  Apr 10  Comment 
Genstar Capital announced its plans to buy eResearch Technology Inc (NASDAQ: ERT) for $8 per share in a deal valued at $400 million. The price represents a 42% premium to ERT's closing level of $7.84 per share on Monday, and 42% above its...
Benzinga  Mar 22  Comment 
Price: $7.30 Forward P/E: 13 Earnings Growth: 40% Projected Sales Growth: 9% Market Cap: $360 million Why It's Featured: Strong earnings growth; lots of cash;  Danger Zones: Still very small; valuations beginning to...
Benzinga  Feb 28  Comment 
Auriga maintains its Buy rating and $9 target price on eResearch (NASDAQ: ERT) as it believes the stock remains undervalued following solid Q4 and outlook. Auriga says, "We are reiterating our BUY rating on eResearch Technology (ERT) on the...
Benzinga  Feb 28  Comment 
Benchmark raises its price target on Buy-rated eResearch Technology (NASDAQ: ERT) to reflect the company's expanding capacity and efficiency. Benchmark comments, "ERT posted strong Q4 results including revenue growth of 16.5% to $52.3 million,...
TheStreet.com  Feb 28  Comment 
Updated from 4:50 p.m. ET to include latest share prices, additional information on Sina.com. NEW YORK (TheStreet) -- Shares of eResearch Technology surged in late trades on Monday after the Philadelphia-based medical technology company...





You may also be interested in articles related to EResearch Technology (ERES):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki